Sign in

Robert Remenar

Director at Cooper-Standard Holdings
Board

About Robert J. Remenar

Independent director at Cooper-Standard Holdings Inc. (CPS) since 2015; age 69. Background spans CEO roles at automotive suppliers (Nexteer, Chassix) and SPAC leadership at Kensington Capital entities; currently serves on CPS’s Audit and Compensation Committees and is designated an Audit Committee financial expert. Education: Master of Business and Professional Accountancy (Walsh College) and undergraduate degree (Central Michigan University). Independence affirmed by the Board’s annual determination; eight of nine nominees are independent overall .

Past Roles

OrganizationRoleTenureCommittees/Impact
Kensington Capital Acquisition Corp. IVChief Operating OfficerMar 2022 – Sep 2022SPAC operating leadership
Kensington Capital Acquisition Corp. IIPresident; Vice Chairman of BoardFeb 2021 – Oct 2021SPAC leadership; capital markets
Kensington Capital Acquisition Corp. IPresident; Vice Chairman of BoardJun 2020 – Nov 2020SPAC leadership; capital markets
Chassix Inc.President & CEOJul 2012 – Jun 2014Automotive chassis systems execution
Nexteer AutomotivePresident & CEODec 2009 – Jun 2012Turnaround and operational leadership
Delphi Steering/Nexteer AutomotivePresidentApr 2002 – Nov 2012Steering systems management
Delphi Corp.Executive positions1998 – 2002Automotive operations
General MotorsExecutive/managerial roles1985 – 1998Manufacturing & engineering

External Roles

OrganizationRoleTenureCommittees/Impact
Samvardhana Motherson International LimitedDirectorCurrentChair: Risk Management; Member: Strategic Relationship, Strategic Business Matters, Global Sustainability
Munro & AssociatesDirectorCurrentBoard service (engineering advisory)
Kensington Capital Acquisition Corp. (I, II)Former DirectorPast 5 yearsFormer public company directorships

Board Governance

  • Committee assignments: Audit and Compensation (not a chair); designated “financial expert” for Audit; Audit and Compensation each met 7 times in 2024 .
  • Independence & leadership: Independent director; CPS has an independent Lead Director (David J. Mastrocola) with specified oversight responsibilities, and 8 of 9 nominees are independent .
  • Attendance & engagement: 8 Board meetings and 22 committee meetings in 2024; average attendance 96%, and each director attended ≥75% of Board/committee meetings; 8 executive sessions held .

Fixed Compensation

Component2024 Amount ($)Notes
Annual cash retainer100,000 Standard non-employee director fee; no chair premium for Remenar
Committee chair fee0 Not a chair
Total cash100,000
  • Director compensation program: Cash retainer $100,000; committee chair +$10,000; Lead Director +$20,000; program unchanged vs prior year .

Performance Compensation

Equity AwardGrant DateShares/UnitsGrant-Date Fair Value ($)Vesting
RSUs (time-vested)May 16, 20247,693 120,000 Earlier of next annual meeting or 1-year anniversary; settlement in stock or cash equivalent at Company’s option
Deferred RSUs (election)Various (aggregate)29,894 N/ADeferred under Director plan; payable in shares within 45 days post board service termination or change of control
  • Equity mix and structure: 2024 director equity grant value targeted at ~120% of base director fee; Remenar’s total director comp was $220,000, split ~$100,000 cash and $120,000 equity (~45% cash / ~55% equity) .
  • No performance metrics tied to director equity; grants are time-based RSUs (no options or PSUs disclosed for directors) .

Other Directorships & Interlocks

CompanyTypeSector OverlapPotential Interlock Consideration
Samvardhana Motherson International LimitedPublicAuto componentsSector overlap with CPS; Board oversight includes related-party review; no FY2024 related party transactions involving Remenar disclosed
Munro & AssociatesPrivateEngineering consultingAdvisory exposure; no CPS transaction disclosure
Kensington Capital Acquisition Corp. I & IIPublic (former)SPACHistorical capital markets networks

Related-Party Transactions: FY2024 disclosure notes a related-party transaction only for Director Van Oss (ownership of CPS 5.625% Senior Notes and related interest), with none reported for Remenar; CPS maintains a formal Related Party Transaction Policy with committee approval requirements .

Expertise & Qualifications

  • Skills matrix: Core industry, senior executive leadership, financial/audit & risk, M&A/capital markets, international markets, engineering/technical, manufacturing/supply chain, innovation & technology strategy .
  • Audit Committee financial expert designation confirmed by Board .
  • Education: Walsh College (Master of Business; Professional Accountancy); Central Michigan University (undergraduate) .

Equity Ownership

As ofCommon Shares OwnedRSUs Counted as Beneficial OwnershipOptions (Exercisable)Total Beneficial Ownership% of Outstanding Shares
Mar 16, 202527,575 37,587 0 65,162 <1% (shares outstanding 17,548,147)
RSU StatusCount
Deferred RSUs29,894
Outstanding and unvested RSUs7,693
  • Stock ownership guidelines: Directors required to hold stock equal to 5x annual cash fee; must retain 75% of net shares from vesting/exercises until compliant; all incumbent non-employee directors meet or are retaining to meet guidelines .
  • Policies: Clawback policy; anti-hedging and anti-pledging policies; Securities Trading Policy governs insider transactions .

Governance Assessment

  • Strengths:

    • Independent director with dual committee service (Audit and Compensation) and Audit Committee financial expert credential—supports oversight of financial reporting, controls, and pay design .
    • Strong engagement metrics (board/committee attendance and executive sessions) indicate active oversight .
    • Balanced director pay structure with substantive equity component and robust ownership guidelines; 2024 director program unchanged (no inflationary ratcheting) .
    • Compensation Committee uses independent consultant (FW Cook) with formal independence assessment; no conflicts noted .
  • Potential conflicts/risks:

    • Sector overlap from his current directorship at Samvardhana Motherson (auto components) could raise perceived interlock concerns; however, CPS’s policy requires committee review of any related-party transactions, and none involving Remenar were disclosed for 2024 .
    • No Section 16(a) filing issues reported for directors generally in 2024 (one isolated late report for an officer), mitigating compliance risk signals .
  • Shareholder confidence indicators:

    • Broad board independence and presence of a Lead Independent Director, regular executive sessions, and ESG oversight integration across committees .
    • 2024 Say-on-Pay approval at 92% (for NEOs) suggests alignment of pay practices with shareholders; though not directly a director pay vote, it reflects overall governance sentiment .

Overall, Remenar’s credentials and committee roles support board effectiveness in financial oversight and compensation governance, with no disclosed related-party or ownership alignment red flags. Continuous monitoring advisable for potential interlocks via external auto supplier board service, consistent with CPS’s related-party policy framework .